(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release
Posted in Austria, European Union, France, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science, United Kingdom
Tagged biotechnology, CEBINA, Central European Biotech Incubator and Accelerator, clinical testing, Clinical Trail, Diarrhoeal diseases, Enterotoxigenic E. coli, ETEC, European Vaccine Initiative, Eveliqure, Eveliqure Biotechnologies, Eveliqure Biotechnologies GmbH, Frank Malinoski, Gábor Somogyi, Healthcare, Horizon 2020, icddr b, PATH, Pharma & Biotech, science, Shigella, ShigETEC, SHIGETECVAX, Travel Diarrhea, University of Gothenburg, vaccine candidate, Wellcome Trust
The first Rhenium-SCT® treatment was accomplished by the interregional professional association for nuclear medicine in Hanau (PRESS RELEASE) HANAU, Germany, 4-Oct-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged affordable skin cancer therapy, basal cell carcinoma, Basal Cell Carcinomas, Cancer, carcinomas, Dermatology, Dr. Holle, epidermal radioisotope therapies, epidermal radioisotope therapy, first Rhenium-SCT treatment Germany, Garching n. Munich, Hanau Rhenium-SCT treatment center, Healthcare, medical device, medicine, NMSC, non-invasive, Non-Melanocytic Skin Cancer, non-melanoma skin cancers, nuclear medicine, OncoBeta® GmbH, painless, painless non-invasive skin cancer treatment, painless skin cancer treatment, Pharma & Biotech, physician, radioisotope, radioisotope Rhenium-188, radionuclide therapy technology, Rehnium-188, Rhenium, Rhenium-188, Rhenium-SCT, science, Shannon D. Brown III, single-session, skin cancer, Squamous cell Carcinoma, Squamous Cell Carcinomas, technology
New recognition of OncoBeta’s success in developing and providing an innovative therapy for non-melanoma skin cancer patients. (PRESS RELEASE) Pasadena, CA, U.S.A., 5-Jul-2019 — /EuropaWire/ — OncoBeta®, a Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin … Read the full press release
Posted in Awards, Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged affordable skin cancer therapy, Award, basal cell carcinoma, Basal Cell Carcinomas, Cancer, carcinomas, Dermatology, epidermal radioisotope therapies, epidermal radioisotope therapy, Garching n. Munich, Healthcare, medical device, medicine, NMSC, non-invasive, Non-Melanocytic Skin Cancer, non-melanoma skin cancers, nuclear medicine, OncoBeta® GmbH, painless, painless non-invasive skin cancer treatment, painless skin cancer treatment, Pharma & Biotech, physician, radioisotope, radioisotope Rhenium-188, radionuclide therapy technology, Red Herring Top 100 North America Award, Rehnium-188, Rhenium, Rhenium-188, Rhenium-SCT, science, Shannon D. Brown III, single-session, skin cancer, Squamous cell Carcinoma, Squamous Cell Carcinomas, technology
The interregional professional association for nuclear medicine in Hanau is the first treatment center in Germany offering Rhenium-SCT® for the treatment of non-melanoma skin cancer (PRESS RELEASE) GARCHING N. MUNICH, Germany, 13-May-2019 — /EuropaWire/ — OncoBeta® GmbH, a commercial stage … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged 1st in Germany, affordable skin cancer therapy, basal cell carcinoma, Basal Cell Carcinomas, Cancer, carcinomas, Dermatology, Dr. med. Lutz-Hendrik Holle, epidermal radioisotope therapies, epidermal radioisotope therapy, Garching n. Munich, Germany, Hanau, Healthcare, medical device, medicine, NMSC, non-invasive, Non-Melanocytic Skin Cancer, non-melanoma skin cancers, nuclear medicine, OncoBeta® GmbH, painless, painless non-invasive skin cancer treatment, painless skin cancer treatment, Pharma & Biotech, physician, radioisotope, radioisotope Rhenium-188, radionuclide therapy technology, Rehnium-188, Rhenium, Rhenium-188, Rhenium-SCT, Rhenium-SCT treatment center, science, Shannon D. Brown III, single-session, skin cancer, Squamous cell Carcinoma, Squamous Cell Carcinomas, technology
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?